Palomar Holdings PLMR
$163.59 +$6.91 (+4.41%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $164.00 +0.25%
Open$159.47
Prev close$156.68
Day range$159.47 – $166.55
Volume524.6K
Market cap$4.30B
P/E (TTM)20.5
Dividend yield0.28%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$386.59M+58.0% YoY
Net profit$65.34M+27.0% YoY
Diluted EPS$2.42+29.4% YoY
Free cash flow$117.96M+44.8% YoY
Operating cash flow$120.56M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Net margin17.6%
Return on equity23.3%
Return on assets6.1%
Liabilities / assets76.4%
Total debt$315.04M
Free cash flow / sales35.9%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $386.59M | $314.42M | $278.94M | $875.97M | $253.36M |
| Total Operating Revenue | $386.59M | $314.42M | $278.94M | $875.97M | $255.63M |
| Total Premiums Earned | $365.39M | $286.95M | $261.44M | $802.64M | $233.46M |
| -Net Premiums Written | $388.57M | $325.18M | $337.92M | $964.02M | $247.57M |
| -Increase Decrease in Net Unearned Premium Reserves | -$23.18M | -$38.23M | -$76.48M | -$161.39M | -$14.11M |
| Fee Revenue and Other Income | $1.49M | $769,000.00 | $1.41M | $5.50M | $1.54M |
| -Fees and Commissions | $1.49M | $769,000.00 | $1.41M | $5.50M | $1.54M |
| Net Investment Income | -$3.02M | $6.34M | -$2.20M | $10.97M | $4.12M |
| Net Realized Gain/Loss on Investments | -$134,000.00 | -$92,000.00 | $7,000.00 | -$164,000.00 | $157,000.00 |
| Interest Income | $22.87M | $20.46M | $18.28M | $57.03M | $16.35M |
| Total Expenses | $301.86M | $244.62M | $225.48M | $622.58M | $182.97M |
| Loss Adjustment Expense | $151.65M | $98.99M | $87.10M | $228.59M | $70.86M |
| Policy Acquisition Expense | $72.35M | $71.26M | $70.32M | $217.13M | $62.87M |
| Underwriting Expenses | $72.72M | $69.43M | $64.91M | $176.46M | $46.90M |
| $5.14M | $4.95M | $3.16M | $392,000.00 | $88,000.00 | |
| -Interest Expense Non-Operating | $5.14M | $4.95M | $3.16M | $392,000.00 | $88,000.00 |
| Pretax Profit | $84.73M | $69.80M | $53.46M | $253.39M | $72.66M |
| Tax | $19.40M | $17.21M | $10.51M | $56.32M | $16.49M |
| Net Profit | $65.34M | $52.59M | $42.95M | $197.07M | $56.17M |
| Profit from Continuing Operations | $65.34M | $52.59M | $42.95M | $197.07M | $56.17M |
| Net Income to Parent Company | $65.34M | $52.59M | $42.95M | $197.07M | $56.17M |
| Net Income to Common Stockholders | $65.34M | $52.59M | $42.95M | $197.07M | $56.17M |
| Basic EPS | $2.48 | $2.00 | $1.62 | $7.40 | $2.12 |
| Diluted EPS | $2.42 | $1.94 | $1.57 | $7.17 | $2.06 |
| Dividend Per Share | $0.45 | – | – | – | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $4.17B | $3.96B | $3.61B | $3.05B | $3.05B |
| Cash and Cash Equivalents | $55.63M | $62.69M | $56.54M | $106.88M | $106.88M |
| Restricted Cash and Cash Equivalents | $0.00 | $15,000.00 | $16,000.00 | $17,000.00 | $17,000.00 |
| Total Investments | $1.76B | $1.68B | $1.56B | $1.35B | $1.35B |
| -Short Term Investments | $783.15M | $752.96M | $697.90M | $618.28M | $618.28M |
| -Equity Investments | $920.92M | $879.42M | $824.16M | $705.24M | $705.24M |
| -Other Invested Assets | $53.97M | $45.88M | $40.41M | $28.50M | $28.50M |
| Receivables | $1.32B | $1.24B | $1.07B | $921.61M | $921.61M |
| -Accounts Receivable | $1.32B | $1.24B | $1.07B | $921.61M | $921.61M |
| Accrued Investment Income | $15.36M | $14.74M | $12.83M | $11.55M | $11.55M |
| Net PPE | $2.65M | $2.67M | $2.30M | $2.55M | $2.55M |
| Goodwill and Other Intangible Assets | $228.43M | $236.76M | $246.17M | $61.05M | $61.05M |
| Prepaid Assets | $453.17M | $445.45M | $406.08M | $355.92M | $355.92M |
| Deferred Policy Acquisition Costs | $162.89M | $153.82M | $141.60M | $127.72M | $127.72M |
| Other Assets | $168.78M | $127.87M | $118.37M | $110.90M | $110.90M |
| Total Liabilities | $3.18B | $2.98B | $2.65B | $2.11B | $2.11B |
| Policy Holders Liabilities | $2.36B | $2.17B | $1.92B | $1.68B | $1.68B |
| Total Deposits | $53.37M | $50.91M | $40.19M | $44.85M | $44.85M |
| Short-Term Debt and Capital Lease Obligation | $21.00M | – | – | – | – |
| -Current Debt | $21.00M | – | – | – | – |
| Payables | $453.68M | $454.76M | $384.53M | $387.08M | $387.08M |
| -Accounts Payable | $453.68M | $454.76M | $378.68M | $387.08M | $387.08M |
| Long Term Debt and Capital Lease Obligation | $294.04M | $295.77M | $297.43M | – | – |
| -Long Term Debt | $294.04M | $295.77M | $297.43M | – | – |
| Total Equity | $984.97M | $980.94M | $959.04M | $942.67M | $942.67M |
| Stockholders' Equity | $984.97M | $980.94M | $959.04M | $942.67M | $942.67M |
| Capital Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Common Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $553.57M | $542.66M | $533.63M | $523.17M | $523.17M |
| Retained Earnings | $497.66M | $453.44M | $441.86M | $422.00M | $422.00M |
| Gains/Losses Not Affecting Retained Earnings | -$66.27M | -$15.16M | -$16.45M | -$2.51M | -$2.51M |
| Non-Current Deferred Liabilities | – | $10.94M | $10.84M | – | – |
| -Total Tax Payable | – | – | $5.85M | – | – |
| -Long Term Equity Investment | – | – | – | $0.00 | $0.00 |
| -Goodwill | – | – | – | $30.47M | $30.47M |
| -Other Intangible Assets | – | – | – | $30.59M | $30.59M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $120.56M | $167.17M | $47.03M | $409.12M | $117.42M |
| Net cash flow from investing | -$129.93M | -$119.73M | -$373.38M | -$353.98M | -$123.55M |
| Net Cash Flow from Continuing Investing Activities | -$129.93M | -$119.73M | -$373.38M | -$353.98M | -$123.55M |
| Net PPE Purchase and Sale | -$117,000.00 | -$416,000.00 | $240,000.00 | $209,000.00 | $94,000.00 |
| Net Business Purchase and Sale | -$3.85M | -$4.49M | -$249.53M | -$69.84M | $4.34M |
| Net Investment Purchase and Sale | -$139.47M | -$102.23M | -$119.59M | -$276.34M | -$125.66M |
| Net Other Investing Changes | $16.02M | -$10.52M | -$2.50M | -$1.03M | -$503,000.00 |
| Financing Cash Flow | $2.30M | -$41.30M | $276.02M | -$28.79M | $1.26M |
| Net Cash Flow from Continuing Financing Activities | $2.30M | -$41.30M | $276.02M | -$28.79M | $1.26M |
| Net Issuance Payments of Debt | $19.14M | $691,000.00 | $297.43M | $0.00 | $0.00 |
| Net Common Stock Issuance | -$8.89M | -$41.02M | -$23.09M | -$37.28M | $134,000.00 |
| Proceeds from Stock Option Exercised | $2.53M | $460,000.00 | $768,000.00 | $4.92M | $409,000.00 |
| Net Other Financing Charges | $1.36M | -$1.43M | $906,000.00 | $3.58M | $720,000.00 |
| Ending Cash Balance | $55.63M | $62.70M | $56.55M | $106.89M | $106.89M |
| Net Change in Cash | -$7.08M | $6.15M | -$50.34M | $26.35M | -$4.87M |
| Beginning Cash Balance | $62.70M | $56.55M | $106.89M | $80.54M | $111.76M |
| Free Cash Flow | $117.96M | $164.69M | $45.03M | $401.99M | $115.58M |
| Capital Expenditure | – | -$2.07M | -$1.99M | -$6.09M | – |
| Net cash flow from continuing operations | – | – | – | $409.12M | – |
| Net Income from Continuing Operations | – | – | – | $197.07M | – |
| Gain/Loss from Continuing Operations | – | – | – | -$11.80M | – |
| Deferred Tax | – | – | – | $1.87M | – |
| Other Non-Cash Items | – | – | – | -$9.93M | – |
| Change in Working Capital | – | – | – | $202.03M | – |
| -Change in Receivables | – | – | – | -$220.61M | – |
| -Change in Prepaid Assets | – | – | – | -$53.47M | – |
| -Change in Loss and Loss Adjustment Expense Reserves | – | – | – | $178.06M | – |
| -Change in Accrued Investment Income | – | – | – | -$2.97M | – |
| -Change in Payables and Accrued Expense | – | – | – | $74.35M | – |
| -Change in Funds Withheld | – | – | – | $16.98M | – |
| -Change in Unearned Premiums | – | – | – | $240.86M | – |
| -Change in Other Working Capital | – | – | – | -$31.18M | – |
| Net Intangibles Purchase and Sale | – | – | – | -$905,000.00 | $4.28M |
No comments yet — be the first to weigh in on PLMR.
Sign in to join the discussion.